Skip to content
Triangle logo TriangleGet started
← Full study record

NCT04172467 · ADVERSE EVENTS

Adverse events

Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients · Source last updated 2022-01-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
12 months
Other-event reporting threshold
0%

Since this is an observational study of clinical routine, there is no studied medicinal product involved in this study and no safety event were extracted as part of this study.

Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Non-interventional Retropspective Observational Study.

Data from 1086 patients (CLL 490, MM 596) were collected from 86 centres.

0 / 00 / 00 / 0

Group identifiers: EG000: Non-interventional Retropspective Observational Study.

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

    Other reported adverse events

    Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

      Complete source fields
      description
      Since this is an observational study of clinical routine, there is no studied medicinal product involved in this study and no safety event were extracted as part of this study.
      event Groups
      1. deaths Num Affected
        0
        deaths Num At Risk
        0
        description
        Data from 1086 patients (CLL 490, MM 596) were collected from 86 centres.
        id
        EG000
        other Num Affected
        0
        other Num At Risk
        0
        serious Num Affected
        0
        serious Num At Risk
        0
        title
        Non-interventional Retropspective Observational Study.
      frequency Threshold
      0
      time Frame
      12 months

      Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

      Preserved source evidence · Not medical advice